Results 201 to 210 of about 48,614 (253)

Nuclear receptors as therapeutic targets in metabolic and cardiovascular disorders. [PDF]

iScience
Li F, Chen Q, Dai Y, Lu L.
europepmc   +1 more source

Structure-activity landscape of Nurr1 (NR4A2) modulators: medicinal chemistry strategies for neurodegenerative disease intervention. [PDF]

RSC Med Chem
Jaidka S, Kumar A, Singh TG, Bhatia R, Singh RK.   +4 more
europepmc   +1 more source

Genomic Crosstalk Between Nuclear Receptors in Hormone-dependent Cancers.

Endocrinology
Campbell MJ.
europepmc   +1 more source

Pleiotropic immunoregulation by bile acids in pathophysiology. [PDF]

Front Immunol
Lin BS, Yin MY, Xie SA, Li P, Li X.
europepmc   +1 more source

Disruption of the SAGA CORE triggers collateral degradation of KAT2A. [PDF]

Nat Commun
Batty P, Beneder H, Schätz C, Onea G, Zaczek M, Kutschat AP, Abele M, Müller S, Superti-Furga G, Winter GE, Seruggia D.   +10 more
europepmc   +1 more source

G protein-coupled receptors in prostate cancer: research progress and therapeutic targets. [PDF]

Front Cell Dev Biol
Xiong W, Zhou B, Shi J, Ni D, Xiong Z.
europepmc   +1 more source

Reclassification of a novel <i>NR2E3</i> variant as likely pathogenic: a case report of autosomal recessive RP37 in siblings. [PDF]

Ophthalmic Genet
Chen V, Lee W, Kang EY, Liu L, Hsiao MC, Wang NK.   +5 more
europepmc   +1 more source

The orphan nuclear receptor NR4A3 is dispensable for resident memory CD8+ T-cell generation. [PDF]

Immunohorizons
Odagiu L, Boulet S, De Sousa DM, Daudelin JF, Labrecque N.   +4 more
europepmc   +1 more source

Structural basis for diosgenin as an inverse agonist of retinoic acid receptor-related orphan receptor γ. [PDF]

Sci Rep
Chen S, Tian S, Liang J, Wang R, Li Y.
europepmc   +1 more source

Orphan nuclear receptor transcription factors as drug targets. [PDF]

Transcription
Safe S, Oany AR, Tsui WN, Lee M, Srivastava V, Upadhyay S, Hailemariam A, Farkas E, Kakwan S, Kearns C, Sivaram G.   +10 more
europepmc   +1 more source